1. Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
    Nor Hidayah Mustafa et al, 2022, Frontiers in Pharmacology CrossRef
  2. Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects
    Yu-Chieh Chang et al, 2023, Biomolecules CrossRef
  3. Knockdown of long non-coding RNA plasmacytoma variant translocation 1 relieves ox-LDL-induced endothelial cell injury through regulating microRNA-30c-5p in atherosclerosis
    Geng Li et al, 2022, Bioengineered CrossRef
  4. Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway
    Jiabao Dong et al, 2022, Analytical Cellular Pathology CrossRef
  5. The Role of NF-κB and Bax/Bcl-2/Caspase-3 Signaling Pathways in the Protective Effects of Sacubitril/Valsartan (Entresto) against HFD/STZ-Induced Diabetic Kidney Disease
    Mohamed Mohany et al, 2022, Biomedicines CrossRef
  6. Preventive effect of LCZ696 on hypoxic pulmonary hypertension in rats via regulating the PI3K/AKT signaling pathway
    Jie Wang et al, 2023, Pulmonary Pharmacology & Therapeutics CrossRef
  7. Top Five Stories of the Cellular Landscape and Therapies of Atherosclerosis: Current Knowledge and Future Perspectives
    Qi Pan et al, 2024, Current Medical Science CrossRef
  8. The history and mystery of sacubitril/valsartan: From clinical trial to the real world
    Mingsong Zhang et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
  9. Sacubitril/valsartan protects against arsenic trioxide induced cardiotoxicity in vivo and in vitro
    Zhiqiang Wu et al, 2022, Toxicology Research CrossRef
  10. A novel circulating biomarker lnc‐MALAT1 for acute myocardial infarction: Its relationship with disease risk, features, cytokines, and major adverse cardiovascular events
    Ruirui Li et al, 2022, Journal of Clinical Laboratory Analysis CrossRef